COMP <GO>
CUVL vs DE // REVENUE GROWTH (YOY)
Clinuvel Pharmaceuticals Limited (NASDAQ) VS. Deere & Company (NYSE) • 15-METRIC TALLY: CUVL 6
— DE 3
▲ REVENUE GROWTH (YOY) LEADER: CUVL
LAST: $5.15 (+1.58%) • MKT CAP: $257.8M
revenue-growth
5.50%
LAST: $660.00 (+3.02%) • MKT CAP: $177.95B
revenue-growth
-11.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CUVL VS. DE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CUVL | DE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 81.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 9.30% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 9.7x | 27.9x | -18.20 | CUVL | /valuation <GO> |
| Free Cash Flow Yield | 10.51% | 3.43% | +7.08 | CUVL | /fcf-yield <GO> |
| Operating Margin | 43.40% | 13.40% | +30.00 | CUVL | /operating-margins <GO> |
| Net Profit Margin | 37.80% | 11.00% | +26.80 | CUVL | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 5.50% | -11.70% | +17.20 | CUVL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.66% | 0.97% | -0.31 | DE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.00 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.2 | 52.5 | -11.30 | DE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.95 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.3x | 32.9x | -22.60 | CUVL | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $257.8M | $177.95B | -$177.69B | DE | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CUVL REV | DE REV | CUVL GROSS % | DE GROSS % | CUVL FCF | DE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $61.1M | $45.68B | 81.2% | — | $27.1M | $6.10B |
| FY 2024 | $57.9M | $51.72B | 81.5% | — | $20.1M | $7.59B |
| FY 2023 | — | $61.25B | — | — | — | $5.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CUVL // BETA —
DE // BETA 0.95